At London Valves 2022, Dr Pankaj Garg presented formal results of a comparative study to investigate aortic flow physiology by cardiac MRI in five patients who received a DurAVR® transcatheter aortic valve (first-in-human). The study compared DurAVR® THV to normal age-height-weight matched controls, other transcatheter aortic valve implants (TAVI) and patients who had surgical aortic valve replacement (SAVR).